Document is current
Any future updates will be listed below
-
Authors
Torimoto, Keiichi
Okada, Yosuke
Nakayamada, Shingo
Kubo, Satoshi
Kurozumi, Akira
Narisawa, Manabu
Tanaka, Yoshiya http://orcid.org/0000-0002-0807-7139
- License Information
-
More Information
Article History
Received: 8 June 2022
Accepted: 31 August 2022
First Online: 7 October 2022
Competing interests
: Dr Tanaka has received speaking fees and/or honoraria from Gilead, Abbvie, Behringer-Ingelheim, Eli Lilly, Mitsubishi-Tanabe, Chugai, Amgen, YL Biologics, Eisai, Astellas, Bristol-Myers, Astra-Zeneca, received research grants from Asahi-Kasei, Abbvie, Chugai, Mitsubishi-Tanabe, Eisai, Takeda, Corrona, Daiichi-Sankyo, Kowa, Behringer-Ingelheim, and consultant fee from Eli Lilly, Daiichi-Sankyo, Taisho, Ayumi, Sanofi, GSK, Abbvie. Dr Torimoto, Dr Okada, Dr Nakayama, Dr Kubo, Dr Kurozumi and Dr Narisawa declare no potential conflict of interest.
